Issue 05 · February 2026Biweekly
The Switch Stack
Where the numbers flip the narrative
#01 #02 #03 #04 #05 #06 #07
The Investigation

The Inconvenient Correlation: Birth Control, Antibiotics, and the Deaths We Don’t Count

On a Tuesday evening in October 2012, Savita Halappanavar asked for an abortion. She was miscarrying, in pain, and developing sepsis. She was told: “This is a Catholic country.” She died on Sunday. Six years later, Ireland repealed the 8th Amendment by a two-thirds majority. What the data says about the link between reproductive rights and the world’s next great pandemic.

By Adaeze Okonkwo · 14 min read
Chapter I

Savita

Savita Halappanavar was 31 years old, a dentist born in Belgaum, India, living in Galway, Ireland. On October 21, 2012, she was admitted to University Hospital Galway, 17 weeks pregnant and miscarrying. Over the next three days, she repeatedly asked for a termination. She was refused. Ireland’s 8th Amendment, written into the constitution in 1983, gave the fetus a right to life equal to the mother’s. Savita developed sepsis. She died on October 28.

The inquest found “medical misadventure.” The nation found something else. Savita’s face appeared on placards, murals, and ultimately in the voting booth. On May 25, 2018, 66.4% of Irish voters repealed the 8th Amendment.

In the first full year after repeal, 6,666 abortions were performed in Ireland. This was not an increase—an estimated 3,000 to 5,000 Irish women had been traveling to Britain annually for the procedure. Over the 35 years of the 8th Amendment, more than 170,000 women made that journey. What changed was not the number of abortions. What changed was that women stopped dying.

The total number of abortions didn’t change. The number of women who died did.

Ireland’s story is instructive, but it is small. The global data tells the same story at a scale that should restructure how we think about public health entirely.

· · ·
Chapter II

The Invisible Pandemic

In 2019, drug-resistant bacteria directly killed 1.27 million people worldwide and contributed to 4.95 million deaths. The September 2024 Lancet update projects this will rise to 1.91 million directly attributable deaths per year by 2050, with a cumulative toll of 39 million over 25 years.

Antimicrobial resistance has no spokesperson, no celebrity ambassador, no ice bucket challenge. It lacks the dramatic visibility of a pandemic, despite killing more people each year than malaria and HIV/AIDS combined. Part of the reason is that AMR does not kill in a way that generates headlines. It kills by making routine infections untreatable—a urinary tract infection that does not respond to antibiotics, a post-surgical wound that turns septic, a child’s ear infection that becomes meningitis.

Antimicrobial resistance is a slow-moving pandemic. Unlike COVID-19, it won’t generate a crisis response until millions have already died. — Dame Sally Davies, UK Special Envoy on AMR

Between 30% and 50% of all antibiotic prescriptions globally are unnecessary. In children, the rate is at least as high—antibiotics prescribed for viral infections where they have zero therapeutic value. Each unnecessary course contributes to the breeding of resistant bacteria.

But here is the finding that complicates everything: the 2024 Lancet data shows that AMR deaths in children under 5 have actually declined 50% since 1990, thanks to improved sanitation, vaccines, and water access in the developing world. Meanwhile, AMR deaths in people over 70 have increased 80%. The AMR crisis is not primarily a pediatric problem anymore. It is increasingly a geriatric one. This matters because the simplest version of the argument—fewer births, fewer pediatric infections, less resistance—does not hold up under scrutiny.

The real argument is more complex. And more interesting.

· · ·
Chapter III

The Market Failure

In 2018, the US Food and Drug Administration approved plazomicin, an antibiotic developed by Achaogen to treat complicated urinary tract infections caused by drug-resistant bacteria. One year later, Achaogen filed for bankruptcy. Not because the drug did not work. Because it worked too well—and was used too rarely.

The best antibiotics are the ones kept in reserve. Last-resort drugs sit on shelves, generating minimal revenue, while the resistant infections they are designed to fight quietly multiply. Melinta Therapeutics followed Achaogen into bankruptcy the same year. Novartis, AstraZeneca, and Sanofi all exited or drastically reduced their antibiotic programs.

The math: a new antibiotic earns an average of $46 million per year in its first five years. Semaglutide—marketed as Ozempic for diabetes and Wegovy for weight loss—earns approximately $25–30 billion per year for Novo Nordisk. The entire global antibiotic market generates roughly $42 billion annually, spread across hundreds of products with fierce generic competition. A single GLP-1 agonist generates more revenue than the most optimistic scenario for the entire antibiotic pipeline.

The perverse incentive is structural. Antibiotics cure infections in days—short courses, no recurring revenue. GLP-1 agonists are taken daily for life—millions of customers, recurring billing, massive ROI. The market rewards drugs for chronic conditions of affluence while the drugs for acute conditions of poverty go unfunded.

Ozempic earns in roughly eight hours what a new antibiotic earns in a year.

· · ·
Chapter IV

Decree 770

On October 1, 1966, Romanian dictator Nicolae Ceaușescu signed Decree 770, banning abortion for women under 45 with fewer than four children. Contraception was restricted. A “celibacy tax” was imposed on childless adults. The birth rate doubled within a year.

Then reality set in. Women found underground means. Maternal mortality quintupled—from approximately 86 per 100,000 live births before the decree to an estimated 150–170 per 100,000 during the 1980s, with some sources citing peaks as high as 545 per 100,000. An estimated 10,000 women died from illegal abortions during the 23 years of Decree 770.

The children who could not be aborted and could not be raised were deposited in state institutions. By 1989, between 100,000 and 170,000 children lived in Romanian orphanages. The conditions were documented by international journalists after Ceaușescu’s execution on December 25, 1989: malnourishment, neglect, physical abuse, and rampant infections treated with massive and indiscriminate antibiotic doses. An estimated 10,000 institutionalized children were HIV-positive by 1990, infected through contaminated needles and blood transfusions.

Decree 770 was repealed on December 26, 1989—one day after the execution.

Today, Romania has one of Europe’s highest rates of antibiotic consumption—approximately 30+ DDD per 1,000 inhabitants per day, compared to roughly 10 in the Netherlands. Romania also has among the EU’s highest antimicrobial resistance rates. The institutional habits forged in Ceaușescu’s orphanages—antibiotic overuse as a substitute for adequate care—appear to have embedded themselves in Romanian medical culture.

This is not proof of a causal chain from banned contraception to antibiotic resistance. It is something more useful: a case study in how governance failure cascades across domains. The same state that was willing to control women’s bodies was incapable of controlling its prescription pads.

· · ·
Chapter V

73 Million

Seventy-three million induced abortions occur worldwide every year. Sixty-one percent of all unintended pregnancies end in abortion. These numbers do not change based on legality. The Guttmacher Institute’s data is unambiguous: abortion rates are similar in countries where the procedure is restricted and those where it is broadly legal. When you exclude the population giants of China and India, rates are actually higher in restrictive countries.

Forty-five percent of all abortions globally are unsafe. In Latin America and Africa, three out of four are unsafe. In Africa, nearly half are performed under what the WHO classifies as “least safe conditions”—untrained providers using dangerous and invasive methods. Approximately 39,000 women die each year from unsafe abortions. Eight percent of all maternal deaths are linked to abortion.

There are 259 million women worldwide who lack access to modern contraception despite wanting to avoid pregnancy. In 2024 alone, UNFPA-supported contraceptives prevented an estimated 18 million unintended pregnancies, 7.5 million unsafe abortions, and 39,000 maternal deaths. Every dollar invested in contraception returns $27 in economic benefits.

The most effective way to reduce abortion is not to ban it. It is to prevent the pregnancies that lead to it. This is not ideology. It is arithmetic.

The idea that some lives matter less is the root of all that is wrong with the world. — Paul Farmer
· · ·
Chapter VI

The Dutch Model

The Netherlands provides sex education beginning at age four. Contraception is covered by health insurance for women under 21. The result: an abortion rate of approximately 8.7 per 1,000 women—among the lowest in Europe. A teen pregnancy rate of 3.8 per 1,000—compared to 15.4 in the United States.

The Netherlands also has one of Europe’s lowest rates of antibiotic consumption, at roughly 10 DDD per 1,000 inhabitants per day, compared to an EU average of approximately 22. Its SWAB national guidelines enforce strict prescribing protocols. Antibiotics are not available over the counter. Antimicrobial resistance rates are consistently among the EU’s lowest.

This is not coincidence. It is the same institutional DNA expressing itself across domains. Evidence-based sex education. Evidence-based prescribing guidelines. Trust in data. Respect for individual autonomy. Investment in prevention rather than punishment.

The Netherlands does not need to argue about abortion rights because it invested in preventing the conditions that lead to abortion. It does not face a catastrophic AMR crisis because it invested in preventing the conditions that breed resistance. The pattern is not contraception causing lower AMR. The pattern is good governance causing both.

· · ·
Chapter VII

The Switch

The simple narrative—that contraception prevents superbugs—is seductive but wrong. Israel has one of the developed world’s highest fertility rates (TFR 3.0) and moderate AMR rates, because its healthcare system is strong. Japan has ultra-low fertility (TFR 1.2) and rising AMR in its elderly population. India’s fertility is declining rapidly but AMR is rising, driven by over-the-counter antibiotic sales and pharmaceutical pollution.

Economic development is the overwhelming confounder. Rich countries have both better contraception access and better antibiotic stewardship. The correlation is real. The causation is indirect.

But the indirect causation is what makes the story important. The same institutional failures that restrict contraception—religious interference in healthcare, weak governance, contempt for evidence, poverty—are the same failures that drive antibiotic misuse. Societies that trust women to make reproductive decisions also trust doctors to make prescribing decisions. Societies that do not trust women with their own bodies do not trust science with their antibiotics.

The “pro-life” framing collapses under its own arithmetic. Countries that restrict contraception have higher abortion rates (just unsafe ones), higher maternal mortality, and higher antibiotic resistance rates. Countries that invest in reproductive autonomy have lower abortion rates, lower maternal mortality, and lower AMR rates. The most effective “pro-life” policy is comprehensive sex education and free contraception.

But this also challenges the pro-choice framing. Abortion access without contraception access is treating symptoms. The Netherlands does not succeed because it has liberal abortion laws. It succeeds because it invested in prevention so thoroughly that abortion is rarely needed.

And it challenges the public health establishment. AMR and reproductive health are researched in separate silos. The WHO tracks both but never connects them. The governance-failure lens—the recognition that the same institutional weaknesses produce both crises—is entirely absent from AMR discourse.

The data does not care about your morals. It does not care about your politics. It cares about institutions. Build them on evidence, and people live. Build them on ideology, and people die—from unsafe abortions and from untreatable infections, from the same broken systems, counted in the same morgues.

Societies that trust women with their own bodies also trust science with their medicine. The correlation is institutional, not biological.

No woman can call herself free who does not own and control her body. — Margaret Sanger, Woman and the New Race (1920)

Note: Margaret Sanger’s legacy is complicated by her documented connections to the eugenics movement. Her contributions to contraception access are acknowledged alongside this historical context.